TrialMedical oncology (Northwood, London, England)2015
Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma.
YaJuan Shao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it